Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases

Palanivel Ganesan,1,2,* Prakash Ramalingam,3,4,* Govindarajan Karthivashan,1,* Young Tag Ko,4 Dong-Kug Choi1,2 1Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea; 2Nanotechnology Research Center and Department of Applied Life Scienc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ganesan P, Ramalingam P, Karthivashan G, Ko YT, Choi DK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/1c2c4fc35003450f9495ba02fb6daa45
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c2c4fc35003450f9495ba02fb6daa45
record_format dspace
spelling oai:doaj.org-article:1c2c4fc35003450f9495ba02fb6daa452021-12-02T04:20:41ZRecent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases1178-2013https://doaj.org/article/1c2c4fc35003450f9495ba02fb6daa452018-03-01T00:00:00Zhttps://www.dovepress.com/recent-developments-in-solid-lipid-nanoparticle-and-surface-modified-s-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Palanivel Ganesan,1,2,* Prakash Ramalingam,3,4,* Govindarajan Karthivashan,1,* Young Tag Ko,4 Dong-Kug Choi1,2 1Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea; 2Nanotechnology Research Center and Department of Applied Life Science, Konkuk University, Chungju, Republic of Korea; 3Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA; 4College of Pharmacy, Gachon University, Incheon, Republic of Korea *These authors contributed equally to this work Abstract: Solid lipid nanoparticle (SLN) delivery systems have a wide applicability in the delivery of phyto-bioactive compounds to treat various chronic diseases, including diabetes, cancer, obesity and neurodegenerative diseases. The multiple benefits of SLN delivery include improved stability, smaller particle size, leaching prevention and enhanced lymphatic uptake of the bioactive compounds through oral delivery. However, the burst release makes the SLN delivery systems inadequate for the oral delivery of various phyto-bioactive compounds that can treat such chronic diseases. Recently, the surface-modified SLN (SMSLN) was observed to overcome this limitation for oral delivery of phyto-bioactive compounds, and there is growing evidence of an enhanced uptake of curcumin delivered orally via SMSLNs in the brain. This review focuses on different SLN and SMSLN systems that are useful for oral delivery of phyto-bioactive compounds to treat various chronic diseases. Keywords: solid lipid nanoparticles, surface-modified solid lipid nanoparticles, chronic diseases, phyto-bioactive compounds, chitosanGanesan PRamalingam PKarthivashan GKo YTChoi DKDove Medical PressarticleSolid-lipid nano particlessurface-modified solid-lipid nanoparticleschronic diseasesphyto-bioactive compoundschitosanMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 1569-1583 (2018)
institution DOAJ
collection DOAJ
language EN
topic Solid-lipid nano particles
surface-modified solid-lipid nanoparticles
chronic diseases
phyto-bioactive compounds
chitosan
Medicine (General)
R5-920
spellingShingle Solid-lipid nano particles
surface-modified solid-lipid nanoparticles
chronic diseases
phyto-bioactive compounds
chitosan
Medicine (General)
R5-920
Ganesan P
Ramalingam P
Karthivashan G
Ko YT
Choi DK
Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
description Palanivel Ganesan,1,2,* Prakash Ramalingam,3,4,* Govindarajan Karthivashan,1,* Young Tag Ko,4 Dong-Kug Choi1,2 1Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea; 2Nanotechnology Research Center and Department of Applied Life Science, Konkuk University, Chungju, Republic of Korea; 3Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA; 4College of Pharmacy, Gachon University, Incheon, Republic of Korea *These authors contributed equally to this work Abstract: Solid lipid nanoparticle (SLN) delivery systems have a wide applicability in the delivery of phyto-bioactive compounds to treat various chronic diseases, including diabetes, cancer, obesity and neurodegenerative diseases. The multiple benefits of SLN delivery include improved stability, smaller particle size, leaching prevention and enhanced lymphatic uptake of the bioactive compounds through oral delivery. However, the burst release makes the SLN delivery systems inadequate for the oral delivery of various phyto-bioactive compounds that can treat such chronic diseases. Recently, the surface-modified SLN (SMSLN) was observed to overcome this limitation for oral delivery of phyto-bioactive compounds, and there is growing evidence of an enhanced uptake of curcumin delivered orally via SMSLNs in the brain. This review focuses on different SLN and SMSLN systems that are useful for oral delivery of phyto-bioactive compounds to treat various chronic diseases. Keywords: solid lipid nanoparticles, surface-modified solid lipid nanoparticles, chronic diseases, phyto-bioactive compounds, chitosan
format article
author Ganesan P
Ramalingam P
Karthivashan G
Ko YT
Choi DK
author_facet Ganesan P
Ramalingam P
Karthivashan G
Ko YT
Choi DK
author_sort Ganesan P
title Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
title_short Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
title_full Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
title_fullStr Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
title_full_unstemmed Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
title_sort recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/1c2c4fc35003450f9495ba02fb6daa45
work_keys_str_mv AT ganesanp recentdevelopmentsinsolidlipidnanoparticleandsurfacemodifiedsolidlipidnanoparticledeliverysystemsfororaldeliveryofphytobioactivecompoundsinvariouschronicdiseases
AT ramalingamp recentdevelopmentsinsolidlipidnanoparticleandsurfacemodifiedsolidlipidnanoparticledeliverysystemsfororaldeliveryofphytobioactivecompoundsinvariouschronicdiseases
AT karthivashang recentdevelopmentsinsolidlipidnanoparticleandsurfacemodifiedsolidlipidnanoparticledeliverysystemsfororaldeliveryofphytobioactivecompoundsinvariouschronicdiseases
AT koyt recentdevelopmentsinsolidlipidnanoparticleandsurfacemodifiedsolidlipidnanoparticledeliverysystemsfororaldeliveryofphytobioactivecompoundsinvariouschronicdiseases
AT choidk recentdevelopmentsinsolidlipidnanoparticleandsurfacemodifiedsolidlipidnanoparticledeliverysystemsfororaldeliveryofphytobioactivecompoundsinvariouschronicdiseases
_version_ 1718401296371810304